To ensure we are providing accurate and timely information, we only list articles on studies that are published in peer-reviewed periodicals and provide information to help you live well with PD. ​ CLICK FOR A FULL LIST OF ARTICLES AND RESEARCH STUDIES

Vulnerability of Parkinson's Patients to COVID-19: A Comprehensive Systematic Review
Rezayi, S., Rahmani Katigari, M., Shahmoradi, L., & Nilashi, M. (2023, April 24). Vulnerability of parkinson’s patients to covid-19 and its consequences and effects on them: A systematic review. Parkinson’s Disease. https://www.hindawi.com/journals/pd/2023/6272982/

This systematic review investigates the susceptibility of Parkinson's disease (PD) patients to COVID-19 and the ensuing consequences. PD, as the second most common neurological disorder, has seen varied impacts on its patients during the COVID-19 pandemic. Employing the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) guidelines, the study conducted a rigorous search in the Medline (through PubMed) and Scopus databases, spanning from inception to January 30, 2022. The Joanna Briggs Institute (JBI) critical appraisal checklist was utilized to assess the selected studies. Notably, a majority of the studies (38%) were conducted in Italy. Among the studies, 17 (58%) were cross-sectional, seven (22%) were cohort, four (12%) were quasi-experimental, two (6%) were case-control, and one (3%) was qualitative in nature. The duration of PD among patients ranged from 3.26 to 13.40 years, with sample sizes varying from 12 to 30,872 participants.
 
Remarkably, despite the exacerbation of PD symptoms in individuals affected by both COVID-19 and Parkinson's disease, some studies identified PD as a risk factor for more severe COVID-19 outcomes. The pandemic period had detrimental effects on PD patients, encompassing motor and nonmotor functioning abnormalities, clinical outcomes, activities of daily living, and other facets of their lives. In conclusion, this study underscores the adverse impact of the COVID-19 pandemic on the health-related quality of life of PD patients and their caregivers. Consequently, due to the exacerbated symptoms observed in PD patients during the ongoing pandemic, these individuals should receive heightened care and supervision to mitigate their exposure to the coronavirus. The integration of modern technologies, such as telemedicine, offers a potential solution to address many of these challenges.

READ THE FULL ARTICLE

PUBLISHED RESEARCH

 To ensure we are providing accurate and timely information, we only list articles on studies that are published in peer-reviewed periodicals and provide information to help you live well with PD.  To find additional papers and research CLICK HERE